Скачать с ютуб Post-MCDA Analysis of Drug-related Harms By Prof David Nutt в хорошем качестве

Post-MCDA Analysis of Drug-related Harms By Prof David Nutt

David Nutt is currently the Edmond J. Safra Professor of Neuropsychopharmacology and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences. In addition to several prestigious appointments in the past, David is currently Chair of DrugScience (formally the Independent Scientific Committee on Drugs (ISCD) and President of the European Brain Council. He has edited the Journal of Psychopharmacology for over two decades and acts as the psychiatry drugs advisor to the British National Formulary. David  broadcasts widely to the general public both on radio and television including BBC science and public affairs programmes on therapeutic as well as illicit drugs, their harms, and their classification.  He has published over 400 original research papers, a similar number of reviews and book chapters, eight government reports on drugs, and 27 books. Take-Home Points: • As all variables (i.e. 16 parameters of drug harms) are on a ratio scale and not absolute numbers, this allows comparison between all drugs being scored. • Weighting is group-specific, probably culturally specific, and likely related to your chosen professional groups. • A repeated study by European scientists revealed results supporting the use of MCDA analysis as an extremely robust process. Full article: https://psychscenehub.com/video/post-...